ArticleMolecular cancer therapeutics2021

ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium.

Pooja Hingorani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.